World Health Organization. Obesity and Overweight. Fact Sheet Number 311. August 2014. http://www.Who.Int/Mediacentre/Factsheets/Fs311/En/. Accessed May 2023
Department of Health. Healthy Lives, Healthy People: A Call to Action on Obesity in England. London: Department of Health; 2011. https://assets.publishing.service.gov.uk. Accessed May 2023
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143:e984–1010.
Article PubMed PubMed Central Google Scholar
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.
Article CAS PubMed Google Scholar
Fruhbeck G, Toplak H, Woodward E, Yumuk V, Maislos M, Oppert JM, Executive Committee of the European Association for the Study of Obesity. Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe. Obes Facts. 2013;6:117–20.
Article PubMed PubMed Central Google Scholar
United Nations World population prospects the 2017 Revision, Key Findings and Advanc Tables; United Nations New York NY, USA 2017. https://www.un.org/fr/desa/world-population-prospects-2017-revision-global-population. Accessed May 2023
Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–48.
Article CAS PubMed Google Scholar
Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231–43.
Article CAS PubMed Google Scholar
Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Heal Aging. 2009;13:708–12.
Liu P, Hao Q, Hai S, Wang H, Cao L, Dong B. Sarcopenia as a predictor of all-cause mortality among community-dwelling older people: a systematic review and meta-analysis. Maturitas. 2017;103:16–22.
Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393:2636–46.
Beaudart C, Rizzoli R, Bruyere, Reginster JY, Biver E. Sarcopenia:burden and challenges for public health. Arch Public Health. 2014;72:45.
Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes. 2005;29:1011–29.
Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18:388–95.
Article CAS PubMed Google Scholar
Visvanathan R, Chapman I. Preventing sarcopaenia in older people. Maturitas. 2010;66:383–8.
Article CAS PubMed Google Scholar
Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, Celis-Morales C. Factors associated with sarcopenia: a cross-sectional analysis using UK Biobank. Maturitas. 2020;133:60–7.
Article CAS PubMed Google Scholar
Jensen GL. Inflammation: roles in aging and sarcopenia. JPEN J Parenter Enteral Nutr. 2008;32:656–9.
Article CAS PubMed Google Scholar
Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B, et al. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas. 2017;96:10–5.
Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45.
Article CAS PubMed Google Scholar
Hong SH, Choi KM. Sarcopenic obesity, insulin resistance and their implications in cardiovascular and metabolic consequences. Int J Mol Sci. 2020;21:494.
Article CAS PubMed PubMed Central Google Scholar
Roubenoff R. Sarcopenic obesity: the confluence of two epidemics. Obes Res. 2004;12(6):887–888.
Barazzoni R, Bischoff SC, Boirie Y, Busetto L, Cederholm T, Dicker D, et al. Sarcopenic obesity: time to meet the challenge. Clin Nutr. 2018;37:1787–93.
Batsis JA, Villareal DT. Sarcopenic obesity in older adults:aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol. 2018;14:513–37.
Article PubMed PubMed Central Google Scholar
Koliaki C, Liatis S, Dalamaga M, Kokkhinos A. Sarcopenic obesity:epidemiologic evidence, pathophysiology and therapeutic perspectives. Curr Obes Rep. 2019;8:458–71.
• Atkins JL, Wannamethee SG. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br J Nutr. 2020;124:1102–13. This paper provides a comprehensive review of the association between sarcopenic obesity and cardiovascular risk factors and disease.
Article CAS PubMed Google Scholar
• Roh E, Choi KM. Health consequences of Sarcopenic Obesity: a narrative review. Front Endocrinol (Lausanne). 2020;11:332. This is a narrative review of the impact of sarcopenic obesity on health outcomes.
Park MJ, Hwang SY, Kim NH, Kim SG, Choi KM, Baik SH, et al. A novel anthropometric parameter, weight-adjusted waist index represents sarcopenic obesity in newly diagnosed type 2 diabetes mellitus. J Obes Metab Syndr. 2023;32:130–40.
Trierweiler H, Kisielewicz G, Hoffmann Jonasson T, Rasmussen Petterle R, Aguiar Moreira C, ZeghbiCochenskiBorba V. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr. 2018;10:25.
Article PubMed PubMed Central Google Scholar
Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. In: Proceedings of the Nutrition Society; 2015; 74:405–412.
Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr. 2020;39:2368–88.
•• Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin Nutr. 2022;41:990–1000. This paper is the consensus statement form the ESPEN and EASO providing details on the definition and diagnostic criteria for sarcopenic obesity.
Article CAS PubMed Google Scholar
Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr. 2021;40:4633–41.
Cruz-Jentoft AJ, Baeyens JP, Bauers JM, et al. Sarcopenia: European consensus on definition and diagnosis:report of the European Working Group on arcopenia in Older People. Age Ageing. 2010;39:412–23.
Article PubMed PubMed Central Google Scholar
Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58.
Article PubMed PubMed Central Google Scholar
Cruz Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia revised consensus on definition and diagnosis. Age Ageing. 2019;48:601–31.
Article PubMed PubMed Central Google Scholar
Zhang X, Xie X, Dou Q, Liu C, Zhang W, Yang Y, et al. Association of sarcopenic obesity with risk of all-cause mortality among adults over a broad range of different settings: an updated meta-analysis. BMC Geriatr. 2019;19:183.
Article PubMed PubMed Central Google Scholar
Saaksjarvi K, Harkanen T, Stenholm S, Schaap L, Lundqvist A, Koskinen S, et al. Probable Sarcopenia, obesity, and risk of all-cause mortality: a pooled analysis of 4612 participants. Gerontology. 2023;69:706–15.
Hamer M, O’Donovan G. Sarcopenic obesity weight loss and mortality:the English longitudinal study of ageing. Am J Clin Nutr. 2017;106:125–9.
Article CAS PubMed Google Scholar
Sanada K, Chen R, Willcox B, Ohara T, Wen A, Takenaka C, Masaki K. Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: the Kuakini Honolulu Heart Program. Nutrition. 2018;46:97–102.
Farmer RE, Mathur R, Schmidt F, Bhaskaran K, Fatemifar G, Eastwood SV, et al. Associations between measures of sarcopenic obesity and risk of cardiovascular disease and mortality: a cohort study and mendelian randomization analysis using the UK biobank. J Am Heart Assoc. 2019;8: e011638.
Article PubMed PubMed Central Google Scholar
Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamethee SG. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc. 2014;62:253–60.
Van Aller C, Lara J, Stephan BCM, Donini LM, Heymsfield S, Katzmarzyk PT, et al. Sarcopenic obesity and overall mortality: results from the application of novel models of body composition phenotypes to the National Health and Nutrition Examination Survey 1999–2004. Clin Nutr. 2019;38:264–70.
•• Liu C, Wong PY, Chung YL, Chow SK, Cheung WH, Law SW, et al. Deciphering the “obesity paradox” in the elderly: a systematic review and meta-analysis of saropenic obesity. Obes Rev. 2023;24:e13534. This is a systematic review and meta-analysis involving over 160000 elderly subjects and provides relatives odds of mortality, metabolic disease outcomes and numerous comorbidity outcomes by the 4 categories: normal, obesity only, sarcop
Comments (0)